Phibro Animal Health (PAHC) Net Income towards Common Stockholders Growth (3y) (2015 - 2026)
Phibro Animal Health (PAHC) Net Income towards Common Stockholders Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 14.04% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 2.87% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 14.78% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Phibro Animal Health | 1.44 Bn | 1.36 Bn | 125.68 Mn | 33.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.74% |
| Dec 31, 2025 | 56.16% |
| Sep 30, 2025 | 90.19% |
| Jun 30, 2025 | 32.01% |
| Mar 31, 2025 | 5.68% |
| Dec 31, 2024 | -43.29% |
| Sep 30, 2024 | 2.20% |
| Jun 30, 2024 | -71.12% |
| Mar 31, 2024 | -11.59% |
| Dec 31, 2023 | -53.66% |
| Sep 30, 2023 | -38.41% |
| Jun 30, 2023 | 31.16% |
| Mar 31, 2023 | -9.40% |
| Dec 31, 2022 | -15.37% |
| Sep 30, 2022 | 15.31% |
| Jun 30, 2022 | 2.18% |
| Mar 31, 2022 | 6.01% |
| Dec 31, 2021 | 5.80% |
| Sep 30, 2021 | -26.29% |
| Jun 30, 2021 | -19.10% |